Skip to content
POM-V Prescription Required Companion Animal

Melosus 0.5 mg/ml Oral Suspension for Cats and Guinea Pigs

Active ingredient: Meloxicam

Form

Liquid

Species

Cats Guinea pig

Manufacturer

CP Pharma Handelsgesellschaft mbH

VMD MA No.

20916/5002

What it's used for

Cats: Alleviation of mild to moderate post-operative pain and inflammation following surgical procedures in cats, e.g. orthopaedic and soft tissue surgery....

Full indications, dosage and side effects ↓
View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Meloxicam

  1. 1

    Ask your vet for a written prescription

    They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.

  2. 2

    Fill it at a registered online retailer

    The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Melosus 0.5 mg/ml Oral Suspension for Cats and Guinea Pigs — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 26 Mar 2026.

Cats:
Alleviation of mild to moderate post-operative pain and inflammation following
surgical procedures in cats, e.g. orthopaedic and soft tissue surgery.
Alleviation of pain and inflammation in acute and chronic musculo-skeletal
disorders in cats.
Guinea pigs:
Alleviation of mild to moderate post-operative pain associated with soft tissue
surgery such as male castration.

Issued: February 2026
AN: 03617/2025
Oral use.
To be administered either mixed with food or directly into the mouth.
Shake well before use.
Avoid introduction of contamination during use.
Cats:
Dosage
Post-operative pain and inflammation following surgical procedures:
After initial treatment with meloxicam solution for injection for cats, continue
treatment 24 hours later with Melosus 0.5 mg/ml oral suspension for cats at a
dosage of 0.05 mg meloxicam/kg body weight. The oral follow-up dose may be
administered once daily (at 24-hour intervals) for up to four days.

Issued: February 2026
AN: 03617/2025
Acute musculo-skeletal disorders:
Initial treatment is a single oral dose of 0.2 mg meloxicam/kg bodyweight on the
first day. Treatment is to be continued once daily by oral administration (at 24-hour
intervals) at a dose of 0.05 mg meloxicam/kg body weight for as long as acute pain
and inflammation persist.
Chronic musculo-skeletal disorders:
Initial treatment is a single oral dose of 0.1 mg meloxicam/kg body weight on the
first day. Treatment is to be continued once daily by oral administration (at 24-hour
intervals) at a maintenance dose of 0.05 mg meloxicam/kg body weight.
A clinical response is normally seen within 7 days. Treatment should be
discontinued after 14 days at the latest if no clinical improvement is apparent.
Route and method of administration
The suspension can be given using the measuring syringe provided in the
package. The syringe fits onto the drop dispenser of the bottle and has a kg-body
weight scale which corresponds to the maintenance dose. Thus, for initiation of the
treatment of chronic musculo-skeletal disorders on the first day, twice the
maintenance volume will be required. For initiation of the treatment of acute
musculo-skeletal disorders on the first day, 4 times the maintenance volume will be
required.
Particular care should be taken with regard to the accuracy of dosing. The
recommended dose should not be exceeded.
Guinea pigs:
Dosage
Post-operative pain associated with soft tissue surgery:
Initial treatment is a single oral dose of 0.2 mg meloxicam/kg body weight on day 1
(pre-surgery). Treatment is to be continued once daily by oral administration (at 24-
hours intervals) at a dose of 0.1 mg meloxicam/kg body weight on day 2 to day 3
(post-surgery).
The dose can, at the discretion of the veterinarian, be titrated up to 0.5 mg/kg in
individual cases. The safety of doses exceeding 0.6 mg/kg has, however, not been
evaluated in guinea pigs.
Route and method of administration
The suspension should be given directly into the mouth using a standard 1 ml
syringe graduated with ml scale and 0.01 ml increments.
Dose of 0.2 mg meloxicam/kg body weight: 0.4 ml/kg body weight
Dose of 0.1 mg meloxicam/kg body weight: 0.2 ml/kg body weight
Use a small container (e.g. a teaspoon) and drop Melosus oral suspension into the
container (it is advised to dispense a few drops more than required into the small
container). Use a standard 1 ml syringe to draw up Melosus according to the
bodyweight of the guinea pig. Administer Melosus with the syringe directly into the
mouth of the guinea pig. Wash the small container with water and dry prior to the
next use.
Do not use the cat syringe with the kg-body weight scale for guinea pigs.

Issued: February 2026
AN: 03617/2025
Do not use in pregnant or lactating animals.
Do not use in cats suffering from gastrointestinal disorders such as irritation and
haemorrhage, impaired hepatic, cardiac or renal function and haemorrhagic
disorders.
Do not use in cases of hypersensitivity to the active substance or to any of the
excipients.
Do not use in cats less than 6 weeks of age.
Do not use in guinea pigs less than 4 weeks of age.
In cats, typical adverse reactions of NSAIDs such as loss of appetite, vomiting,
diarrhoea, faecal occult blood, apathy and renal failure have occasionally been
reported. In very rare cases elevated liver enzymes have been reported.

Issued: February 2026
AN: 03617/2025
These adverse reactions are in most cases transient and disappear following
termination of the treatment but in very rare cases may be serious or fatal.
If adverse reactions occur, treatment should be discontinued and the advice of a
veterinarian should be sought.
The frequency of adverse reactions is defined using the following convention:
- very common (more than 1 in 10 animals treated displaying adverse reactions)
- common (more than 1 but less than 10 animals in 100 animals treated)
- uncommon (more than 1 but less than 10 animals in 1,000 animals treated)
- rare (more than 1 but less than 10 animals in 10,000 animals treated)
- very rare (less than 1 animal in 10,000 animals treated, including isolated
reports).
None.

Special precautions for use in animals
Avoid use in any dehydrated, hypovolaemic or hypotensive animal, as there is a
potential risk of renal toxicity.
Post-operative use in cats and guinea pigs:
In case additional pain relief is required, multimodal pain therapy should be
considered.
Chronic musculoskeletal disorders in cats:
Response to long-term therapy should be monitored at regular intervals by a
veterinary surgeon.
Melosus 0.5 mg/ml oral suspension for cats should not be used following
parenteral injection of meloxicam or any other Non-Steroidal Anti-Inflammatory
Drugs (NSAIDs) as appropriate dosage regimens for such follow-up treatments
have not been established in cats.
Special precautions to be taken by the person administering the veterinary
medicinal product to animals
People with known hypersensitivity to NSAIDs should avoid contact with the
veterinary medicinal product.
In case of accidental ingestion, seek medical advice immediately and show the
package leaflet or the label to the physician.
interaction
Other NSAIDs, diuretics, anticoagulants, aminoglycoside antibiotics and
substances with high protein binding may compete for binding and thus lead to
toxic effects. Melosus must not be administered in conjunction with other NSAIDs
or glucocorticosteroids. Concurrent administration of potential nephrotoxic
veterinary medicinal products should be avoided.
Pre-treatment with anti-inflammatory substances may result in additional or
increased adverse effects and accordingly a treatment-free period with such
veterinary medicinal products should be observed for at least 24 hours before
commencement of treatment. The treatment-free period, however, should take into
account the pharmacokinetic properties of the products used previously.
This veterinary medicinal product does not require any special storage conditions.
Not applicable.
5.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.

Medication costs adding up?

Pet insurance can cover prescription medications. Find the right policy for your pet.

Compare insurance

Find cheaper vets near you

Compare vet consultation prices in your area. Save on procedures and get a prescription to buy medications online.